Skip to main content
. 2017 Feb 23;61(3):e00498-16. doi: 10.1128/AAC.00498-16

TABLE 1.

Selected input parametersa

Variable description Baseline value Reference(s)
Protection from reinfection in latent infection state 0.5 41, 42
Proportion progressing rapidly to active TB 0.15 43
Baseline life expectancy (yr) 70 44
TB-specific mortality rate/yr 0.17 45
Probability of endogenous reactivation over the patient's lifetime 5% 46
Rate of diagnosis and treatment initiation/yr 0.69 21
Relative infectiousness of patients on ineffective treatment 0.2 47
Rate of spontaneous recovery from active TB/yr 0.17 45
% discontinuing treatment prior to completion
    First-line treatment 6 21
    Second-line treatment 23 35
% experiencing early relapse
    Drug-sensitive TB 4 48, 49
    RIF-resistant TB 16 50
    FQ-resistant TB 12 50
    PZA-resistant TB 8 14
a

Additional details are provided in Table S3 in the supplemental material.